Xtant Medical Holdings, Inc. (XTNT) Stock Price

XTNTStock

$0.29−59.51%52W

Market Cap$40.22M

P/E9.46x

PEG Ratio1.74

Div yield—

Beta-0.29

XTNT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-53.69%

Price vs S&P 500 (4W)-13.60%

PEG Ratio1.74

VGM Score48.42

P/E Ratio (Annual)9.46x

P/CF (Annual)3.75x

Book Value / Share (Quarterly)$0.29

P/TBV (Annual)2.17x

Revenue Growth (3Y)32.20%

Cash Flow / Share (Quarterly)$-0.01

Price vs S&P 500 (YTD)-75.36%

Gross Margin (TTM)59.39%

Net Profit Margin (TTM)-10.17%

EPS (TTM)$-0.08

10-Day Avg Trading Volume0.10M

EPS Excl Extra (TTM)$-0.08

Revenue Growth (5Y)20.22%

EPS (Annual)$0.03

ROI (Annual)6.51%

Gross Margin (Annual)62.92%

Net Profit Margin (5Y Avg)-6.60%

Cash / Share (Quarterly)$0.07

P/E Basic Excl Extra (TTM)23.84x

Revenue Growth QoQ (YoY)-34.96%

P/E Normalized (Annual)9.46x

ROA (Last FY)5.28%

Revenue Growth TTM (YoY)-14.27%

EBITD / Share (TTM)$-0.02

ROE (5Y Avg)-13.55%

Operating Margin (TTM)-6.59%

Cash Flow / Share (Annual)$0.07

P/B Ratio1.18x

P/B Ratio (Quarterly)1.48x

Net Income / Employee (Annual)$32,900

EV / Revenue (TTM)0.55x

Net Interest Coverage (TTM)2.92x

ROA (TTM)-12.44%

EV / EBITDA (TTM)5.35x

EPS Incl Extra (Annual)$0.03

Current Ratio (Annual)2.65x

Quick Ratio (Quarterly)0.99x

3-Month Avg Trading Volume1.23M

52-Week Price Return-59.51%

EV / Free Cash Flow (Annual)5.92x

P/E Incl Extra (TTM)23.84x

Revenue / Employee (TTM)$725,300

Tangible BV / Share (Quarterly)$0.28

P/S Ratio (Annual)0.35x

Asset Turnover (Annual)1.42x

52-Week High$0.95

Operating Margin (5Y Avg)-3.87%

EPS Excl Extra (Annual)$0.03

CapEx CAGR (5Y)9.04%

Tangible BV CAGR (5Y)29.22%

26-Week Price Return-43.78%

Quick Ratio (Annual)1.55x

13-Week Price Return-36.29%

Total Debt / Equity (Annual)0.50x

Current Ratio (Quarterly)2.16x

Enterprise Value$60.21M

Revenue / Share Growth (5Y)-13.76%

Asset Turnover (TTM)1.22x

Book Value / Share Growth (5Y)14.22%

Revenue / Employee (Annual)$886,900

Inventory Turnover (Annual)1.44x

Pretax Margin (Annual)5.23%

Cash / Share (Annual)$0.12

3-Month Return Std Dev83.80%

Gross Margin (5Y Avg)59.21%

Net Income / Employee (TTM)$-73,800

EBITDA CAGR (5Y)64.07%

EBITDA Interim CAGR (5Y)45.07%

ROE (Last FY)9.76%

Net Interest Coverage (Annual)-2.44x

EPS Basic Excl Extra (Annual)$0.03

P/FCF (TTM)4.63x

Receivables Turnover (TTM)4.72x

EV / Free Cash Flow (TTM)50.96x

Total Debt / Equity (Quarterly)0.58x

EPS Incl Extra (TTM)$-0.08

Receivables Turnover (Annual)6.96x

ROI (TTM)-15.94%

P/S Ratio (TTM)0.43x

Pretax Margin (5Y Avg)-6.61%

Revenue / Share (Annual)$0.89

Tangible BV / Share (Annual)$0.36

Forward P/E45.04x

Price vs S&P 500 (52W)-75.04%

P/E Ratio (TTM)23.84x

Year-to-Date Return-63.43%

5-Day Price Return-12.86%

EPS Normalized (Annual)$0.03

ROA (5Y Avg)-6.90%

Net Profit Margin (Annual)3.71%

Month-to-Date Return-19.26%

Cash Flow / Share (TTM)$0.05

EBITD / Share (Annual)$0.11

Operating Margin (Annual)7.89%

LT Debt / Equity (Annual)0.22x

P/CF (TTM)82.55x

ROI (5Y Avg)-8.27%

P/E Excl Extra (TTM)23.84x

LT Debt / Equity (Quarterly)0.18x

EPS Basic Excl Extra (TTM)$-0.08

P/TBV (Quarterly)1.49x

P/B Ratio (Annual)2.15x

Inventory Turnover (TTM)1.21x

Pretax Margin (TTM)-8.44%

Book Value / Share (Annual)$0.36

Price vs S&P 500 (13W)-38.97%

Beta-0.29x

P/FCF (Annual)4.63x

Revenue / Share (TTM)$0.78

ROE (TTM)-23.45%

52-Week Low$0.27

vGradeB

gGradeC

mGradeD

vgmGradeC

XTNT Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 11, 2026	-$0.02	-$0.03	-35.50%(-$0.01)
Q1 2026	May 13, 2026	-$0.02	-$0.02	+9.80%(+$0.00)
Q4 2025	Mar 31, 2026	$0.00	-$0.01	+0.00%(-$0.01)
Q3 2025	Nov 10, 2025	$0.00	$0.01	+0.00%(+$0.01)
Q2 2025	Aug 12, 2025	-$0.02	$0.03	+248.50%(+$0.05)

XTNT Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

4.22

4.13

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
XTNTXtant Medical Holdings, Inc.	B	C	D	0.4x	20.2%	59.4%	-6.6%	$0.29
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About Xtant Medical Holdings, Inc.

Xtant Medical Holdings develops and commercializes orthobiologics and spinal implant systems for complex spinal fusion, deformity, and degenerative procedures. Its product portfolio includes OsteoSponge, OsteoSelect Plus, OsteoWrap, and 3Demin allografts, sold to orthopedic spine surgeons and neurosurgeons. The company generates the majority of its revenue from the U.S. market.

XTNT Next Earnings Report

Report dateNov 10, 2026

QuarterQ3 2026

Report timeBMO

EPS estimate-$0.02

Revenue estimate$25.48M

Also reporting on Nov 10, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

MYOMyomo Inc.Orthopedic & Prosthetic Devices
POCIPrecision Optics Corporation, Inc. Common StockElectromedical Equipment
MBAIMBody AI Ltd. Ordinary ShareX-Ray Equipment
SYPRSypris Solutions IncIndustrial Instruments
MINDMIND Technology, Inc. Common Stock (DE)Defense Systems & Equipment
RPIDRapid Micro Biosystems, Inc. Class A Common StockLab Analytical Instruments
PRPOPrecipio, Inc. Common StockLab Analytical Instruments
HBIOHarvard Bioscience IncLab Analytical Instruments

Same SIC sector, outside this company's own industry.

Analyst Sentiment

4.1

Buy

Consensus rating

52-Week Range

Low$0.27

High$0.95